CD274 and non-small cell lung carcinoma: In this large study of advanced NSCLC treated with ICI across four institutions, we demonstrated that a risk prediction model that combined Clinical + DeepRadiomics was generalizable and was non-inferior to the Clinical + PD-L1 model currently used by oncologists to predict PFS-6 months.